Bladder Cancer Clinical Trial

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

Summary

A study to evaluate the safety and tolerability of nivolumab or nivolumab Plus BMS-986205 with or without BCG in BCG-Unresponsive non-muscle invasive Bladder Cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Pathologically demonstrated BCG-unresponsive, carcinoma in situ (CIS)-containing high-risk non-muscle-invasive bladder cancer (NMIBC) defined as CIS with or without papillary component
Participants must have CIS to be eligible.
Predominant histologic component (> 50%) must be urothelial (transitional cell) carcinoma
Eastern Cooperative Oncology Group (ECOG) performance status 0-1

Exclusion Criteria:

Sign of locally advanced disease or metastatic bladder cancer
Urothelial cancer (UC) in the upper genitourinary tract (kidneys, renal collecting systems, ureters) within 24 months of enrollment
Prior immuno-oncology therapy

Other protocol-defined inclusion/exclusion criteria apply

Study is for people with:

Bladder Cancer

Phase:

Phase 2

Estimated Enrollment:

142

Study ID:

NCT03519256

Recruitment Status:

Terminated

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 85 Locations for this study

See Locations Near You

Local Institution - 0044
Los Angeles California, 90033, United States
Local Institution - 0081
Riverside California, 92505, United States
Local Institution - 0087
San Francisco California, 94158, United States
Local Institution - 0125
Tampa Florida, 33612, United States
Local Institution - 0056
Hapeville Georgia, 30354, United States
Local Institution - 0023
New Lenox Illinois, 60451, United States
Wichita Urology Group
Wichita Kansas, 67226, United States
Local Institution - 0001
Baltimore Maryland, 21287, United States
Local Institution - 0077
Ann Arbor Michigan, 48109, United States
Local Institution - 0032
Minneapolis Minnesota, 55455, United States
Local Institution - 0040
Omaha Nebraska, 68114, United States
Local Institution - 0144
New Brunswick New Jersey, 08903, United States
Deleware Valley Urology, LLC
Voorhees New Jersey, 08043, United States
Local Institution - 0051
New York New York, 10016, United States
Local Institution - 0058
Columbus Ohio, 43212, United States
Local Institution - 0036
Bala-Cynwyd Pennsylvania, 19004, United States
Local Institution - 0049
Charleston South Carolina, 29425, United States
Local Institution - 0002
Myrtle Beach South Carolina, 29572, United States
Local Institution - 0057
Chattanooga Tennessee, 37403, United States
Urology Clinics Of North Texas, Pa
Dallas Texas, 75231, United States
Local Institution - 0048
Houston Texas, 77030, United States
Local Institution - 0140
Houston Texas, 77030, United States
Local Institution - 0047
Lubbock Texas, 79415, United States
Urology San Antonio Research, Pa
San Antonio Texas, 78229, United States
Local Institution - 0141
Seattle Washington, 98195, United States
Local Institution - 0068
Capital Federal Buenos Aires, 1426, Argentina
Local Institution - 0065
Capital Federal Distrito Federal, C1280, Argentina
Local Institution - 0089
Ciudad Autonoma Buenos Aires Distrito Federal, 1118, Argentina
Local Institution
Viedma RIO Negro, 8500, Argentina
Instituto Oncologico De Cordoba
Cordoba , 5000, Argentina
Local Institution - 0137
Mendoza , 5500, Argentina
Local Institution - 0146
Camperdown New South Wales, 2050, Australia
Local Institution - 0148
St Leonards New South Wales, 2065, Australia
Local Institution - 0072
Fortaleza Ceara, 60135, Brazil
Local Institution - 0151
Curitiba Parana, 80810, Brazil
Local Institution - 0073
Porto Alegre RIO Grande DO SUL, 91350, Brazil
Local Institution
Itacorubi, Florianopolis Santa Catarina, 88034, Brazil
Local Institution - 0078
Jau Sao Paulo, 17210, Brazil
Local Institution - 0150
Rio de Janeiro , 20230, Brazil
Local Institution - 0074
Sao Paulo , 01246, Brazil
Local Institution - 0143
North York Ontario, M2K 1, Canada
Local Institution - 0086
Toronto Ontario, M4N 3, Canada
Local Institution - 0084
Toronto Ontario, M5G 2, Canada
Local Institution - 0046
Quebec City Quebec, G1J 1, Canada
Local Institution - 0154
Santiago Metropolitana, 84203, Chile
Local Institution - 0069
Santiago Metropolitana, , Chile
Local Institution - 0128
Beijing Beijing, 10002, China
Local Institution - 0131
Beijing Beijing, 10003, China
Local Institution - 0116
Beijing Beijing, 10014, China
Local Institution - 0099
Beijing Beijing, 10019, China
Local Institution - 0129
Chongqing Chongqing, 40003, China
Local Institution - 0108
Fuzhou Fujian, 35000, China
Local Institution - 0117
Guangzhou Guangdong, 51000, China
Local Institution - 0102
Nanjing Jiangsu, 21000, China
Local Institution - 0109
Nan Chang Jiangxi, 33000, China
Local Institution - 0112
Jinan Shandong, 25001, China
Local Institution - 0111
Yantai Shandong, 26400, China
Local Institution - 0098
Shanghai Shanghai, 20002, China
Local Institution - 0094
Shanghai Shanghai, 20003, China
Local Institution - 0097
Shanghai Shanghai, 20004, China
Local Institution - 0120
Chengdu Sichuan, 61004, China
Local Institution - 0133
Tianjin Tianjin, 30021, China
Local Institution - 0126
Hangzhou Zhejiang, 31000, China
Local Institution - 0027
Suresnes Hauts-de-Seine, 92151, France
Local Institution - 0028
Angers Maine-et-Loire, 49933, France
Local Institution - 0031
Bordeaux Cedex , 33076, France
Local Institution - 0088
Lille , 59037, France
Local Institution - 0091
Strasbourg , 67200, France
Local Institution - 0093
Hong Kong , , Hong Kong
IRCCS Istituto Nazionale Tumori Milano
Milano , 20133, Italy
Instituto Nazionale Tumori Fondazione G. Pascale
Napoli , 80131, Italy
Azienda Ospedaliera Universitaria Pisana
Pisa , 56126, Italy
Local Institution - 0062
Tuxtla Gutierrez Chiapas, 29083, Mexico
Local Institution - 0055
Ciudad de Mexico Distrito Federal, 06100, Mexico
Local Institution - 0004
Amsterdam , 1066 , Netherlands
Local Institution - 0003
Nijmegen , 6525G, Netherlands
Local Institution - 0005
Utrecht , 3584C, Netherlands
Local Institution - 0070
Omsk , 64401, Russian Federation
Local Institution - 0054
Saint-Petersburg , 19404, Russian Federation
Local Institution - 0153
Saint-Petersburg , 19903, Russian Federation
Local Institution
Madrid , 28041, Spain
Local Institution - 0033
Malaga , 29010, Spain
Local Institution - 0139
Santander , 39008, Spain
Local Institution - 0136
Valencia , 46010, Spain
Local Institution
Chelmsford Essex, CM1 7, United Kingdom
Local Institution
London Greater London, N18 1, United Kingdom
Local Institution - 0013
Southampton Hampshire, SO16 , United Kingdom
Local Institution - 0015
Lancaster , LA1 4, United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Phase:

Phase 2

Estimated Enrollment:

142

Study ID:

NCT03519256

Recruitment Status:

Terminated

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.